Product Information
HYLENEX 150 UNITS/ML VIAL is a brand product labeled by Antares Pharma, Inc., priced at $53.6877 per ML under NDC 18657011704. Its NADAC has been published 181 times since Mar 23, 2022.
Strength
150 [USP'U]/mL
Manufacturer
Antares Pharma, Inc.NDC
18657011704
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
HYALURONIDASE (HUMAN RECOMBINANT)Approval Type
Biologic (BLA)
FDA Application
BLA021859On Market Since
12/2/2005
Pharmacological Classes
Price Statistics
The NADAC for HYLENEX 150 UNITS/ML VIAL has been published 181 times since Mar 23, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $53.6877 per ML |
|---|---|
| All-time high | $53.7465 (Aug 12, 2026) |
| All-time low | $53.2842 (Aug 20, 2025) |
| 52-week high | $53.7465 |
| 52-week low | $53.3589 |
| Median price | $53.4275 |
| Average price | $53.4672 |
| Largest weekly change | -0.4% (Apr 17, 2024) |
| Weeks tracked | 181 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hyaluronidase market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Antares Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hyaluronidase market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYLENEX 150 UNITS/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HYLENEX 150 UNITS/ML VIAL, manufactured by Antares Pharma, Inc., is $53.6877 per ML (NDC 18657011704), effective Sep 30, 2026.
How has the price of HYLENEX 150 UNITS/ML VIAL changed over time?
Over the history we have for it, the NADAC for HYLENEX 150 UNITS/ML VIAL has held within roughly two percent of its current level. It has been tracked across 181 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for HYLENEX 150 UNITS/ML VIAL?
Since Mar 23, 2022, the NADAC for HYLENEX 150 UNITS/ML VIAL has ranged from a low of $53.2842 (Aug 20, 2025) to a high of $53.7465 (Aug 12, 2026), with a median of $53.4275 per ML.
Are there cheaper alternatives to HYLENEX 150 UNITS/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of HYLENEX 150 UNITS/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYLENEX 150 UNITS/ML VIAL?
HYLENEX 150 UNITS/ML VIAL (NDC 18657011704) is labeled by Antares Pharma, Inc., and CMS classifies it as a brand product.